We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Validating Non-invasive Measurements of Central Blood Pressure in Type 2 Diabetic Patients (IMPRESS)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01538290
First Posted: February 24, 2012
Last Update Posted: June 12, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
University of Aarhus
  Purpose
The investigators want to validate two non-invasive devices for the determination of central blood pressure, i.e. blood pressure in the aorta (artery leaving the heart).

Condition
Diabetes Mellitus, Type 2 Blood Pressure

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Validating Non-invasive Measurements of Central Blood Pressure in Type 2 Diabetic

Further study details as provided by University of Aarhus:

Enrollment: 34
Study Start Date: November 2011
Study Completion Date: March 2012
Primary Completion Date: March 2012 (Final data collection date for primary outcome measure)
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patient with type 2 diabetes mellitus referred to elective coronary angiography.
Criteria

Inclusion Criteria:

  • Diabetes Mellitus, Type 2
  • Age above 18 years

Exclusion Criteria:

  • Atrial fibrillation or other cardiac arrhythmia
  • known stenosis of aorta or arteria subclavia/brachialis
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01538290


Locations
Denmark
Aarhus University Hospital, Skejby, Department of Cardiology
Aarhus, Denmark, 8000
Sponsors and Collaborators
University of Aarhus
Investigators
Study Director: Hans Erik Bøtker, MD,Professor Aarhus University Hospital, Skejby, Department of Cardiology
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: University of Aarhus
ClinicalTrials.gov Identifier: NCT01538290     History of Changes
Other Study ID Numbers: M-20110166
First Submitted: February 20, 2012
First Posted: February 24, 2012
Last Update Posted: June 12, 2012
Last Verified: June 2012

Keywords provided by University of Aarhus:
Calibration
Validation
Transfer function
SphygmoCor
Arteriograph

Additional relevant MeSH terms:
Diabetes Mellitus
Diabetes Mellitus, Type 2
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases